Loading Events

All Events

Xconomy: What’s Hot in Boston Biotech

May 16, 2018 @ 12:30 pm - 6:30 pm

  • This event has passed.

This half-day forum and networking event features some of Boston biotech’s top entrepreneurs, investors, and thought leaders exploring some of the most interesting developments in the local life sciences horizon.

In many ways, 2017 marked a turning point for biomedical innovation. The FDA approved the first U.S. gene therapy, the first CAR-T cellular immunotherapy, the first cancer drug based on a genetic signature, and the first smartphone app to treat substance abuse. Add to that the first successful Phase 3 trial for an RNA interference drug, and 2017 was a year in which medicine began to change significantly.

Yet with those changes come significant questions. How will the U.S. healthcare system handle these newer, longer-lasting treatments? Will there finally be a drug price reckoning as new therapies push costs higher—and will biopharma adapt with innovative payment models? Elsewhere, will setbacks emerge as CRISPR-Cas9 gene editing speeds towards human testing? Will combination treatments expand the reach of cancer immunotherapy, or pose new obstacles?


May 16, 2018
12:30 pm - 6:30 pm
Event Tags:
Event Website


Broad Institute
415 Main Street
Cambridge, MA 02142 United States
Venue Website